The results showed country-specific challenges, such as elevated OTA in southern Europe and FUM across Latin America and ...

Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on ...

Multiple myeloma (MM) remains a complex and heterogeneous hematologic malignancy with evolving therapeutic challenges. In recent years, immunotherapy has ...

An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

New biomarkers enhance multiple sclerosis (MS) diagnosis, enabling earlier detection and improved patient care, transforming ...

The National Multiple Sclerosis Society (NMSS) announced a number of new funding opportunities aimed to bolster MS research and training. Support originates both from the Society and outside entities.

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests.

SAN DIEGO — Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients with non-relapsing secondary progressive multiple sclerosis ...

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis — and a new study suggests that supplementing it in high doses could help reduce symptoms.

Rising temperatures because of climate change are increasing the risk of human exposure to mycotoxins, according to the European Environment Agency (EEA).

New research testing the newly proposed McDonald Criteria showed that they boost diagnostic yield.

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer anti-inflammatory benefits in multiple sclerosis.